Description of Collaborative Activity: |
FDA and NIST participate in the Steering Committee for an NCI-funded research program, “Integrating Biospecimen Science Approaches into Clinical Assay Development.” Investigators under this research program are brought together with NCI, FDA and NIST experts to review research data and progress and discuss potential collaborative activities that may include joint research projects as well as jointly prepared publications, biospecimen SOPs and best practices. |
Type of Collaborative Activity: |
Committee, Advisory Group, or Work Group
|
